Advanced in Osteosarcoma
Advanced in Osteosarcoma
Stc Pediatrics LLC
300 E Hunting Park Ave, St Christophers Ped Assoc, 
Philadelphia, PA 

Overview

Gregory Halligan is a Pediatrics specialist and a Hematologist in Philadelphia, Pennsylvania. Dr. Halligan is rated as an Advanced provider by MediFind in the treatment of Osteosarcoma. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Rhabdomyosarcoma, Ewing Sarcoma, and Neuroblastoma.

His clinical research consists of co-authoring 7 peer reviewed articles and participating in 34 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 5 clinical trials in the study of Osteosarcoma.

Specialties
Pediatrics
Hematology
Oncology
Licenses
Specialist in PA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

STC PEDIATRICS LLC
300 E Hunting Park Ave, St Christophers Ped Assoc, Philadelphia, PA 19124
Other Locations
STC PEDIATRICS LLC
160 E Erie Ave, Philadelphia, PA 19134

Additional Areas of Focus

Dr. Halligan has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


34 Clinical Trials

Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Renal Tumors Classification, Biology, and Banking Study
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
View 33 Less Clinical Trials
Similar Doctors
Distinguished in Osteosarcoma
Hematology | Oncology
Distinguished in Osteosarcoma
Hematology | Oncology

Abramson Cancer Center Radnor

145 King Of Prussia Road, Floor 2, Suite 200 North, 
Radnor, PA 
 (12.5 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Lee Hartner is a Hematologist and an Oncologist in Radnor, Pennsylvania. Dr. Hartner is rated as a Distinguished provider by MediFind in the treatment of Osteosarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Retroperitoneal Liposarcoma, Liposarcoma, Gastrostomy, and Endoscopy. Dr. Hartner is currently accepting new patients.

Advanced in Osteosarcoma
Hematology | Oncology
Advanced in Osteosarcoma
Hematology | Oncology

Regional Cancer Care Associates LLC

1 Riverview Plz, Fl 2, 
Red Bank, NJ 
 (60.5 miles away)
Languages Spoken:
English

Andrew Pecora is a Hematologist and an Oncologist in Red Bank, New Jersey. Dr. Pecora is rated as a Distinguished provider by MediFind in the treatment of Osteosarcoma. His top areas of expertise are Epithelioid Sarcoma, Melanoma, Merkel Cell Carcinoma, Bone Marrow Transplant, and Tissue Biopsy.

Advanced in Osteosarcoma
Hematology Oncology | Hematology | Oncology
Advanced in Osteosarcoma
Hematology Oncology | Hematology | Oncology

Cmc Dept Of Medicine Group PA

1 Cooper Plz, 
Camden, NJ 
 (4.9 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Polina Khrizman is a Hematologist Oncology specialist and a Hematologist in Camden, New Jersey. Dr. Khrizman is rated as a Distinguished provider by MediFind in the treatment of Osteosarcoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Khrizman is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Halligan's expertise for a condition
ConditionClose
      View All 60 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile